EAM
Empery Asset Management Portfolio holdings
AUM
$16.8M
1-Year Est. Return
55.89%
1 Year Est. Return
-55.89%
AUM
$18.5M
AUM Growth
-$2.81M
(-13%)
Holding
88
Top Buys
| 1 | +$4.5M | |
| 2 | +$2.07M | |
| 3 | +$1.29M | |
| 4 |
Applied Therapeutics
APLT
|
+$640K |
| 5 |
Sharps Technology Inc Warrant
STSSW
|
+$231K |
Top Sells
| 1 | +$1.2M | |
| 2 | +$1.1M | |
| 3 | +$688K | |
| 4 |
NiSun International Enterprise Development Group
NISN
|
+$658K |
| 5 |
The Oncology Institute
TOI
|
+$504K |
Sector Composition
| 1 | Healthcare | 25.83% |
| 2 | Technology | 25.02% |
| 3 | Consumer Staples | 0.38% |
| 4 | Energy | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Imperial Petroleum
IMPP
$179M
| – | – |
-3,833
|
|
||
77
InMed Pharmaceuticals
INM
$5.1M
| – | – |
-123
|
|
||
|
78
NiSun International Enterprise Development Group
NISN
$18.2M
| – | – |
-67,256
|
|
||
79
Rafael Holdings
RFL
$48.4M
| – | – |
-12,151
|
|
||
|
SBFM
80
Sunshine Biopharma
SBFM
$8.79M
| – | – |
-225
|
|
||
81
Soleno Therapeutics
SLNO
$3.51B
| – | – |
-93,427
|
|
||
|
82
The Oncology Institute
TOI
$387M
| – | – |
-70,733
|
|
||
|
VLNS
83
DELISTED
The Valens Company, Inc. Common Shares
VLNS
| – | – |
-400,000
|
|
||
|
STAB
84
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
| – | – |
-333,016
|
|
||
|
AGTC
85
DELISTED
Applied Genetic Technologies Corporation
AGTC
| – | – |
-100,000
|
|
||
|
CALA
86
DELISTED
Calithera Biosciences, Inc
CALA
| – | – |
-38,796
|
|
||
|
IMRNW
87
DELISTED
Immuron Limited Warrants
IMRNW
| – | – |
-46,161
|
|
||
|
BRCC.WS
88
DELISTED
BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a
BRCC.WS
| – | – |
-269,212
|
|